{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:01:18Z","timestamp":1762506078739,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.4158\/ep.12.6.670","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:41:20Z","timestamp":1365198080000},"page":"670-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bisphosphonate Treatment of Tumor-Induced Hypercalcemia in a Toddler: Case Report and Review of Related Literature"],"prefix":"10.1016","volume":"12","author":[{"given":"Lucy D.","family":"Mastrandrea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine H.","family":"Albini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.12.6.670_bb0005","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1097-0142(19930215)71:4<1309::AID-CNCR2820710423>3.0.CO;2-M","article-title":"Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center","volume":"71","author":"Vassilopoulou-Sellin","year":"1993","journal-title":"Cancer."},{"key":"10.4158\/EP.12.6.670_bb0010","first-page":"179","article-title":"Pathogenesis and management of cancer associated hypercalcemia","volume":"21","author":"Ralston","year":"1994","journal-title":"Cancer Surv."},{"key":"10.4158\/EP.12.6.670_bb0015","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/1097-0142(19930701)72:1<256::AID-CNCR2820720145>3.0.CO;2-D","article-title":"Hypercalcemia complicating childhood malignancies","volume":"72","author":"McKay","year":"1993","journal-title":"Cancer."},{"key":"10.4158\/EP.12.6.670_bb0020","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/1097-0142(19841115)54:10<2132::AID-CNCR2820541013>3.0.CO;2-V","article-title":"Hypercalcemia preferentially occurs in unusual forms of childhood non-Hodgkin\u2019s lymphoma, rhabdomyosarcoma, and Wilms\u2019 tumor: a study of 11 cases","volume":"54","author":"Leblanc","year":"1984","journal-title":"Cancer."},{"key":"10.4158\/EP.12.6.670_bb0025","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1002\/1097-0142(197912)44:6<2280::AID-CNCR2820440642>3.0.CO;2-Z","article-title":"Hypercalcemia complicating childhood malignancies: a report of seven cases with some pathophysiological considerations","volume":"44","author":"Harguindey","year":"1979","journal-title":"Cancer."},{"key":"10.4158\/EP.12.6.670_bb0030","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0022-3476(97)80030-3","article-title":"Childhood cancer and hypercalcemia: report of a case treated with pamidronate","volume":"130","author":"Kutluk","year":"1997","journal-title":"J Pediatr."},{"issue":"4 Pt 1","key":"10.4158\/EP.12.6.670_bb0035","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1542\/peds.102.4.990","article-title":"Bisphosphonates for treatment of childhood hypercalcemia","volume":"102","author":"Lteif","year":"1998","journal-title":"Pediatrics."},{"key":"10.4158\/EP.12.6.670_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1096-911X(199802)30:2<117::AID-MPO9>3.0.CO;2-L","article-title":"Use of pamidronate in the management of acute cancer-related hypercalcemia in children","volume":"30","author":"Young","year":"1998","journal-title":"Med Pediatr Oncol."},{"key":"10.4158\/EP.12.6.670_bb0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.mph.0000151932.47598.00","article-title":"Hypercalcemia and childhood cancer: a 7-year experience","volume":"27","author":"Kerdudo","year":"2005","journal-title":"J Pediatr Hematol Oncol."},{"author":"Claudius","key":"10.4158\/EP.12.6.670_bb0050"},{"key":"10.4158\/EP.12.6.670_bb0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/adc.76.1.73","volume":"76","author":"Allgrove","year":"1997","journal-title":"Bisphosphonates. Arch Dis Child."},{"key":"10.4158\/EP.12.6.670_bb0060","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/0140-6736(93)92935-M","article-title":"Mineralisation defects with pamidronate therapy for Paget\u2019s disease","volume":"342","author":"Adamson","year":"1993","journal-title":"Lancet."},{"key":"10.4158\/EP.12.6.670_bb0065","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00005792-199707000-00005","article-title":"Long-term effects of bisphosphonates on the growing skeleton: studies of young patients with severe osteoporosis","volume":"76","author":"Brumsen","year":"1997","journal-title":"Medicine (Baltimore)."},{"key":"10.4158\/EP.12.6.670_bb0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7748\/ns2001.10.16.5.47.c3100","article-title":"Osteogenesis imperfecta: an overview","volume":"16","author":"Clark","year":"2001","journal-title":"Nurs Stand."},{"key":"10.4158\/EP.12.6.670_bb0075","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00008480-200012000-00016","article-title":"Osteogenesis imperfecta: perspectives and opportunities","volume":"12","author":"Byers","year":"2000","journal-title":"Curr Opin Pediatr."},{"key":"10.4158\/EP.12.6.670_bb0080","first-page":"1846","article-title":"Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age","volume":"85","author":"Plotkin","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.12.6.670_bb0085","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/adc.86.5.356","article-title":"Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta","volume":"86","author":"\u00c5str\u00f6m","year":"2002","journal-title":"Arch Dis Child."},{"key":"10.4158\/EP.12.6.670_bb0090","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1542\/peds.111.3.573","article-title":"Intravenous bisphosphonate therapy in children with osteogenesis imperfecta","volume":"111","author":"Falk","year":"2003","journal-title":"Pediatrics."},{"key":"10.4158\/EP.12.6.670_bb0095","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1359\/JBMR.050213","article-title":"Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome","volume":"20","author":"Munns","year":"2005","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.12.6.670_bb0100","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(94)90069-8","article-title":"Long-term effects of intravenous pamidronate in fibrous dysplasia of bone","volume":"343","author":"Liens","year":"1994","journal-title":"Lancet."},{"key":"10.4158\/EP.12.6.670_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1592\/phco.24.2.195.33143","article-title":"Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents","volume":"24","author":"Robinson","year":"2004","journal-title":"Pharmacotherapy."},{"issue":"Suppl 3","key":"10.4158\/EP.12.6.670_bb0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2002-34071","article-title":"Venous thromboembolism in cancer patients: expanding horizons","volume":"28","author":"Bergqvist","year":"2002","journal-title":"Semin Thromb Hemost."},{"key":"10.4158\/EP.12.6.670_bb0115","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1759::AID-CNCR1>3.0.CO;2-7","article-title":"Diagnosis of cancer-associated vascular disorders","volume":"77","author":"Naschitz","year":"1996","journal-title":"Cancer."},{"key":"10.4158\/EP.12.6.670_bb0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9343(93)90282-T","article-title":"Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages","volume":"95","author":"Nussbaum","year":"1993","journal-title":"Am J Med."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20435074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20435074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/4344176440L07R22.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:45:55Z","timestamp":1761515155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20435074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1530891X20435074"],"URL":"https:\/\/doi.org\/10.4158\/ep.12.6.670","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisphosphonate Treatment of Tumor-Induced Hypercalcemia in a Toddler: Case Report and Review of Related Literature","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.12.6.670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}